Journal of Autism and Developmental Disorders

, Volume 37, Issue 2, pp 210–217 | Cite as

MMR-Vaccine and Regression in Autism Spectrum Disorders: Negative Results Presented from Japan

Original Paper

Abstract

It has been suggested that the measles, mumps, and rubella vaccine (MMR) is a cause of regressive autism. As MMR was used in Japan only between 1989 and 1993, this time period affords a natural experiment to examine this hypothesis. Data on 904 patients with autism spectrum disorders (ASD) were analyzed. During the period of MMR usage no significant difference was found in the incidence of regression between MMR-vaccinated children and non-vaccinated children. Among the proportion and incidence of regression across the three MMR-program-related periods (before, during and after MMR usage), no significant difference was found between those who had received MMR and those who had not. Moreover, the incidence of regression did not change significantly across the three periods.

Keywords

MMR Autism ASD Regression 

References

  1. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders. (4th ed.). Washington, D. C.: Author.Google Scholar
  2. Azuma, H., Ueno, K., Fujita, K., Maekawa, H., Ishikuma, T., & Sano, H. (1998). Nihonban WISC-III Tinou-Kensaho. Nihonbunkakagakusha (Japanese version of WISC-III: Translated and standardized to Japanese children by the ad hoc committee).Google Scholar
  3. Fombonne, E., & Chakrabarti, S. (2001). No evidence for a new variant of measles–mumps–rubella-induced autism. Pediatrics, 108, E58.PubMedCrossRefGoogle Scholar
  4. Hoshino, Y., Kaneko, M., Yashima, Y., Kumashiro, H., Volkmar, F. R., & Cohen, D. J. (1987). Clinical features of autistic children with setback course in their infancy. Japanese Journal of Psychiatry and Neurology, 41, 237–245.PubMedGoogle Scholar
  5. Kaye, J. A., del Mar Melero-Montes, M., & Jick, H. (2001). Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ, 322, 460–463.PubMedCrossRefGoogle Scholar
  6. Kurita, H. (1996). Specificity and developmental consequences of speech loss in children with pervasive developmental disorders. Psychiatry and Clinical Neurosciences, 50, 363–387.Google Scholar
  7. Madsen, K. M., Hviid, A., Vestergaard, M., Schendel, D., Wohlfahrt, J., Thorsen, P., Olsen, J., & Melbye, M. (2002) A population-based study of measles, mumps, and rubella vaccination and autism. New England Journal of Medicine, 347, 1477–1482.PubMedCrossRefGoogle Scholar
  8. Makela, A., Nuorti, J. P., & Peltola, H. (2002). Neurologic disorders after measles–mumps–rubella vaccination. Pediatrics, 110, 957–963.PubMedCrossRefGoogle Scholar
  9. Shopler, E., Reichler, R., Bashford, A., Lansing, M. D., & Marcus, L. M. (1990). Psycoeducational profile-revised (PEP-R) . Austin, TC-Pro-Ed. (Translated to Japanese by Ibaraki T, 1995, Kawashima-syoten, Tokyo.).Google Scholar
  10. Sugiura, A., & Yamada, A. (1991). Aseptic meningitis as a complication of mumps vaccination. The Pediatric Infectious Disease Journal, 10, 209–213.PubMedCrossRefGoogle Scholar
  11. Takahashi, H., Arai, S., Tanaka-Taya, K., & Okabe, N. (2001). Autism and infection/immunization episodes in Japan. Japanese Journal of Infectious Diseases, 54, 78–79.PubMedGoogle Scholar
  12. Takahashi, H., Suzumura, S., Shirakisawa, F., Wada, N., Tanaka-Taya, K., Arai, S., Okabe, N., Ichikawa, H., & Sato, T. (2003). An epidemiological study on Japanese autism concerning routine childhood immunization history. Japanese Journal of Infectious Diseases, 56, 114–117.PubMedGoogle Scholar
  13. Tanaka, K-K. (1987). Tanaka-Binet tinou kensaho. Tokyo: Taken shuppan publisher (in Japanese).Google Scholar
  14. Taylor, B., Miller, E., Farrington, C. P., Petropoulos, M. C., Favot-Mayaud, I., Jun, L., & Waight, P. A. (1999). Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet, 353, 2026–2029.PubMedCrossRefGoogle Scholar
  15. Taylor, B., Miller, E., Lingram, L., Andrews, N., Simmons, A., & Stowe, J. (2002). Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ, 324, 393–396.PubMedCrossRefGoogle Scholar
  16. Tuchman, R. F., & Rapin, I. (1997). Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. Pediatrics, 99, 560–566.PubMedCrossRefGoogle Scholar
  17. Wakefield, A. J., Murch, S. H., Anthony, A., Linnell, J., Casson, D. M., Malik, M., Berelowitz, M., Dhillon, A. P., Thomson, M. A., Harvey, P., Valentine, A., Davies, S. E., & Walker-Smith, J. A. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 351, 637–641.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Tokio Uchiyama
    • 1
    • 2
  • Michiko Kurosawa
    • 3
  • Yutaka Inaba
    • 3
  1. 1.Department of Human WelfareOtsuma Women’s UniversityTama-city, TokyoJapan
  2. 2.Yokohama Psycho-developmental clinicYokohamaJapan
  3. 3.Department of Epidemiology and Environmental HealthJuntendo University School of MedicineTokyoJapan

Personalised recommendations